Annual Report to the Nation on the Status of Cancer, Featuring Cancer in Men and Women Age 20–49 Years

Journal of the National Cancer Institute - Tập 111 Số 12 - Trang 1279-1297 - 2019
Elizabeth Ward1, Recinda Sherman1, S. Jane Henley1, Ahmedin Jemal1, David A. Siegel1, Eric J. Feuer1, Albert U. Firth1, Betsy Kohler1, Susan Scott1, Jiemin Ma1, Robert N. Anderson1, Vicki B. Benard1, Kathleen A. Cronin1
1North American Association of Central Cancer Registries, Inc, 2050 W. Iles, Ste A, Springfield, IL 62704-4191

Tóm tắt

AbstractBackgroundThe American Cancer Society, Centers for Disease Control and Prevention, National Cancer Institute, and North American Association of Central Cancer Registries provide annual updates on cancer occurrence and trends by cancer type, sex, race, ethnicity, and age in the United States. This year’s report highlights the cancer burden among men and women age 20–49 years.MethodsIncidence data for the years 1999 to 2015 from the Centers for Disease Control and Prevention- and National Cancer Institute–funded population-based cancer registry programs compiled by the North American Association of Central Cancer Registries and death data for the years 1999 to 2016 from the National Vital Statistics System were used. Trends in age-standardized incidence and death rates, estimated by joinpoint, were expressed as average annual percent change.ResultsOverall cancer incidence rates (per 100 000) for all ages during 2011–2015 were 494.3 among male patients and 420.5 among female patients; during the same time period, incidence rates decreased 2.1% (95% confidence interval [CI] = −2.6% to −1.6%) per year in men and were stable in females. Overall cancer death rates (per 100 000) for all ages during 2012–2016 were 193.1 among male patients and 137.7 among female patients. During 2012–2016, overall cancer death rates for all ages decreased 1.8% (95% CI = −1.8% to −1.8%) per year in male patients and 1.4% (95% CI = −1.4% to −1.4%) per year in females. Important changes in trends were stabilization of thyroid cancer incidence rates in women and rapid declines in death rates for melanoma of the skin (both sexes). Among adults age 20–49 years, overall cancer incidence rates were substantially lower among men (115.3 per 100 000) than among women (203.3 per 100 000); cancers with the highest incidence rates (per 100 000) among men were colon and rectum (13.1), testis (10.7), and melanoma of the skin (9.8), and among women were breast (73.2), thyroid (28.4), and melanoma of the skin (14.1). During 2011 to 2015, the incidence of all invasive cancers combined among adults age 20–49 years decreased −0.7% (95% CI = −1.0% to −0.4%) among men and increased among women (1.3%, 95% CI = 0.7% to 1.9%). The death rate for (per 100 000) adults age 20–49 years for all cancer sites combined during 2012 to 2016 was 22.8 among men and 27.1 among women; during the same time period, death rates decreased 2.3% (95% CI = −2.4% to −2.2%) per year among men and 1.7% (95% CI = −1.8% to −1.6%) per year among women.ConclusionsAmong people of all ages and ages 20–49 years, favorable as well as unfavorable trends in site-specific cancer incidence were observed, whereas trends in death rates were generally favorable. Characterizing the cancer burden may inform research and cancer-control efforts.

Từ khóa


Tài liệu tham khảo

Wingo, 1998, Cancer incidence and mortality, 1973-1995: a report card for the U.S, Cancer, 82, 1197, 10.1002/(SICI)1097-0142(19980315)82:6<1197::AID-CNCR26>3.0.CO;2-0

Wingo, 1999, Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking, J Natl Cancer Inst, 91, 675, 10.1093/jnci/91.8.675

Ries, 2000, The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer, Cancer, 88, 2398, 10.1002/(SICI)1097-0142(20000515)88:10<2398::AID-CNCR26>3.0.CO;2-I

Howe, 2001, Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends, J Natl Cancer Inst, 93, 824, 10.1093/jnci/93.11.824

Edwards, 2002, Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden, Cancer, 94, 2766, 10.1002/cncr.10593

Weir, 2003, Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control, J Natl Cancer Inst, 95, 1276, 10.1093/jnci/djg040

Jemal, 2004, Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival, Cancer, 101, 3, 10.1002/cncr.20288

Edwards, 2005, Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment, J Natl Cancer Inst, 97, 1407, 10.1093/jnci/dji289

Howe, 2006, Annual report to the nation on the status of cancer, 1975-2003, featuring cancer among U.S. Hispanic/Latino populations, Cancer, 107, 1711, 10.1002/cncr.22193

Espey, 2007, Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska Natives, Cancer, 110, 2119, 10.1002/cncr.23044

Jemal, 2008, Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control, J Natl Cancer Inst, 100, 1672, 10.1093/jnci/djn389

Edwards, 2010, Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates, Cancer, 116, 544, 10.1002/cncr.24760

Kohler, 2011, Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system, J Natl Cancer Inst, 103, 714, 10.1093/jnci/djr077

Eheman, 2012, Annual report to the nation on the status of cancer, 1975-2008, featuring cancers associated with excess weight and lack of sufficient physical activity, Cancer, 118, 2338, 10.1002/cncr.27514

Jemal, 2013, Annual report to the nation on the status of cancer, 1975-2009, featuring the burden and trends in human papillomavirus (HPV)-associated cancers and HPV vaccination coverage levels, J Natl Cancer Inst, 105, 175, 10.1093/jnci/djs491

Edwards, 2014, Annual report to the nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer, Cancer, 120, 1290, 10.1002/cncr.28509

Kohler, 2015, Annual report to the nation on the status of cancer, 1975-2011, featuring incidence of breast cancer subtypes by race/ethnicity, poverty, and state, J Natl Cancer Inst, 107, djv048., 10.1093/jnci/djv048

Ryerson, 2016, Annual report to the nation on the status of cancer, 1975-2012, featuring the increasing incidence of liver cancer, Cancer, 122, 1312, 10.1002/cncr.29936

Jemal, 2017, Annual report to the nation on the status of cancer, 1975-2014, featuring survival, J Natl Cancer Inst, 109, 10.1093/jnci/djx030

Cronin, 2018, Annual report to the nation on the status of cancer, part I: national cancer statistics, Cancer, 124, 2785, 10.1002/cncr.31551

Negoita, 2018, Annual report to the nation on the status of cancer, part II: recent changes in prostate cancer trends and disease characteristics, Cancer, 124, 2801, 10.1002/cncr.31549

Fidler, 2017, Cancer incidence and mortality among young adults aged 20-39 years worldwide in 2012: a population-based study, Lancet Oncol, 18, 1579, 10.1016/S1470-2045(17)30677-0

Lortet-Tieulent, 2016, U.S. Burden of cancer by race and ethnicity according to disability-adjusted life years, Am J Prev Med, 51, 673, 10.1016/j.amepre.2016.07.039

Bradley, 2008, Productivity costs of cancer mortality in the United States: 2000-2020, J Natl Cancer Inst, 100, 1763, 10.1093/jnci/djn384

Barr, 2016, Incidence and incidence trends of the most frequent cancers in adolescent and young adult Americans, including “nonmalignant/noninvasive” tumors, Cancer, 122, 1000, 10.1002/cncr.29867

Sung, 2019, Emerging cancer trends among young adults in the USA: analysis of a population-based cancer registry, Lancet Public Health, 4, e137, 10.1016/S2468-2667(18)30267-6

Cook, 2009, Sex disparities in cancer incidence by period and age, Cancer Epidemiol Biomarkers Prev, 18, 1174, 10.1158/1055-9965.EPI-08-1118

Copeland, 2018

Ostrom, 2018, CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011-2015, Neuro Oncol, 20(suppl 4), iv1, 10.1093/neuonc/noy131

2015

Weir, 2014, Evaluation of North American Association of Central Cancer Registries’ (NAACCR) data for use in population-based cancer survival studies, J Natl Cancer Inst Monogr, 2014, 198, 10.1093/jncimonographs/lgu018

Johnson, 2018, Cancer in North America: 2011-2015 Volume Four: Cancer Survival in the United States and Canada 2008-2014

Kim, 2000, Permutation tests for joinpoint regression with applications to cancer rates, Stat Med, 19, 335, 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z

Clegg, 2009, Estimating average annual per cent change in trend analysis, Stat Med, 28, 3670, 10.1002/sim.3733

Underwood, 2015, Decreasing trend in tobacco-related cancer incidence, United States 2005-2009, J Community Health, 40, 414, 10.1007/s10900-014-9951-6

Lim, 2017, Trends in thyroid cancer incidence and mortality in the United States, 1974-2013, JAMA, 317, 1338, 10.1001/jama.2017.2719

Davies, 2015, American Association of Clinical Endocrinologists and American College of Endocrinology disease state clinical review: the increasing incidence of thyroid cancer, Endocr Pract, 21, 686, 10.4158/EP14466.DSCR

Shi, 2017, Changes in thyroid cancer incidence, post-2009 American Thyroid Association guidelines, Laryngoscope, 127, 2437, 10.1002/lary.26473

Luke, 2017, Targeted agents and immunotherapies: optimizing outcomes in melanoma, Nat Rev Clin Oncol, 14, 463, 10.1038/nrclinonc.2017.43

Uprety, 2018, Survival trends among patients with metastatic melanoma in the pretargeted and the post-targeted era: a US population-based study, Melanoma Res, 28, 56, 10.1097/CMR.0000000000000394

Jemal, 2015, Prostate cancer incidence and PSA testing patterns in relation to USPSTF screening recommendations, JAMA, 314, 2054, 10.1001/jama.2015.14905

Siegel, 2017, Colorectal cancer incidence patterns in the United States, J Natl Cancer Inst, 109, 1974, 10.1093/jnci/djw322

Henley, 2016, Vital signs: disparities in tobacco-related cancer incidence and mortality - United States, 2004-2013, MMWR Morb Mortal Wkly Rep, 65, 1212, 10.15585/mmwr.mm6544a3

Loomis, 2018, Identifying occupational carcinogens: an update from the IARC Monographs, Occup Environ Med, 75, 593, 10.1136/oemed-2017-104944

Pinkhasov, 2010, Are men shortchanged on health? Perspective on health care utilization and health risk behavior in men and women in the United States, Int J Clin Pract, 64, 475, 10.1111/j.1742-1241.2009.02290.x

Kim, 2018, Sex differences in cancer: epidemiology, genetics and therapy, Biomol Ther (Seoul), 26, 335, 10.4062/biomolther.2018.103

Cook, 2011, Sex disparities in cancer mortality and survival, Cancer Epidemiol Biomarkers Prev, 20, 1629, 10.1158/1055-9965.EPI-11-0246

Miller, 2016, Cancer treatment and survivorship statistics, 2016, CA Cancer J Clin, 66, 271, 10.3322/caac.21349

Jemal, 2018, Incidence of lung cancer among young women, N Engl J Med, 379, 990

Walker, 2018, National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years - United States, 2017, MMWR Morb Mortal Wkly Rep, 67, 909, 10.15585/mmwr.mm6733a1

Chollet-Hinton, 2016, Breast cancer biologic and etiologic heterogeneity by young age and menopausal status in the Carolina Breast Cancer Study: a case-control study, Breast Cancer Res, 18, 79., 10.1186/s13058-016-0736-y

Shoemaker, 2018, Differences in breast cancer incidence among young women aged 20-49 years by stage and tumor characteristics, age, race, and ethnicity, 2004-2013, Breast Cancer Res Treat, 169, 595, 10.1007/s10549-018-4699-9

Warner, 2013, Reproductive factors and risk of premenopausal breast cancer by age at diagnosis: are there differences before and after age 40?, Breast Cancer Res Treat, 142, 165, 10.1007/s10549-013-2721-9

Weiderpass, 2004, A prospective study of body size in different periods of life and risk of premenopausal breast cancer, Cancer Epidemiol Biomarkers Prev, 13, 1121, 10.1158/1055-9965.1121.13.7

Wu, 2013, Physical activity and risk of breast cancer: a meta-analysis of prospective studies, Breast Cancer Res Treat, 137, 869, 10.1007/s10549-012-2396-7

Liu, 2015, Links between alcohol consumption and breast cancer: a look at the evidence, Womens Health (Lond Engl), 11, 65, 10.2217/WHE.14.62

Gapstur, Cancer Epidemiology and Prevention

Bevers, 2015, Breast cancer risk reduction therapy: the low-hanging fruit, J Natl Compr Canc Netw, 13, 376, 10.6004/jnccn.2015.0052

Armstrong, 2014, Management of women at high risk of breast cancer, BMJ, 348, g2756., 10.1136/bmj.g2756

Ademuyiwa, 2016, Managing breast cancer in younger women: challenges and solutions, Breast Cancer (Dove Med Press), 8, 1

Howlader, 2018, Differences in breast cancer survival by molecular subtypes in the United States, Cancer Epidemiol Biomarkers Prev, 27, 619, 10.1158/1055-9965.EPI-17-0627

Johnson, 2013, Incidence of breast cancer with distant involvement among women in the United States, 1976 to 2009, JAMA, 309, 800, 10.1001/jama.2013.776

DeSantis, 2019, Trends in stage at diagnosis for young breast cancer patients in the United States, Breast Cancer Res Treat, 173, 743, 10.1007/s10549-018-5042-1

Bhandari, 2017, Colorectal cancer is a leading cause of cancer incidence and mortality among adults younger than 50 years in the USA: a SEER-based analysis with comparison to other young-onset cancers, J Investig Med, 65, 311, 10.1136/jim-2016-000229

Siegel, 2017, Colorectal cancer mortality rates in adults aged 20 to 54 years in the United States, 1970-2014, JAMA, 318, 572, 10.1001/jama.2017.7630

Wolf, 2018, Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society, CA Cancer J Clin, 68, 250, 10.3322/caac.21457

Ghazarian, 2015, Recent trends in the incidence of testicular germ cell tumors in the United States, Andrology, 3, 13, 10.1111/andr.288

Stang, 2015, A survey of etiologic hypotheses among testicular cancer researchers, Andrology, 3, 19, 10.1111/andr.306

Fung, 2018, Toxicities associated with cisplatin-based chemotherapy and radiotherapy in long-term testicular cancer survivors, Adv Urol, 2018, 1., 10.1155/2018/8671832

Wiemels, 2010, Epidemiology and etiology of meningioma, J Neurooncol, 99, 307, 10.1007/s11060-010-0386-3

Qi, 2013, Reproductive and exogenous hormone factors in relation to risk of meningioma in women: a meta-analysis, PLoS One, 8, e83261., 10.1371/journal.pone.0083261

Vroonen, 2019, Epidemiology and management challenges in prolactinomas, Neuroendocrinology, 10.1159/000497746

Wu, 2018, Presenting symptoms and prognostic factors for symptomatic outcomes following resection of meningioma, World Neurosurg, 111, e149, 10.1016/j.wneu.2017.12.012

Molitch, 2017, Diagnosis and treatment of pituitary adenomas: a review, JAMA, 317, 516, 10.1001/jama.2016.19699

Pereira, 2014, Long-term effects of treatment of pituitary adenomas, Handb Clin Neurol, 124, 361, 10.1016/B978-0-444-59602-4.00024-1

Roser, 2012, Meningiomas, nerve sheath tumors, and pituitary tumors: diagnosis and treatment, Hematol Oncol Clin North Am, 26, 855, 10.1016/j.hoc.2012.04.005

Boscoe, Differential reporting of in situ colorectal cancer in New York State and the United States, J Registry Manag, 45, 33

Barr, 2006, Classification schemes for tumors diagnosed in adolescents and young adults, Cancer, 106, 1425, 10.1002/cncr.21773

Chen, 2019, Implementing precision cancer medicine in the genomic era, Semin Cancer Biol, 55, 16, 10.1016/j.semcancer.2018.05.009

Simpson, 2015, Cancer biomarkers: the role of structured data reporting, Arch Pathol Lab Med, 139, 587, 10.5858/arpa.2014-0082-RA

Duggan, 2016, The Surveillance, Epidemiology, and End Results (SEER) program and pathology: toward strengthening the critical relationship, Am J Surg Pathol, 40, e94, 10.1097/PAS.0000000000000749

Penberthy, 2014, The value of billing data from oncology practice to supplement treatment information for cancer surveillance, J Registry Manag, 41, 57

Hernandez, 2014, Enhancing central cancer registry treatment data using physician medical claims: a Florida pilot project, J Registry Manag, 41, 51

Singh, 2017, Socioeconomic and racial/ethnic disparities in cancer mortality, incidence, and survival in the United States, 1950-2014: over six decades of changing patterns and widening inequalities, J Environ Public Health, 2017, 2819372., 10.1155/2017/2819372

Ward, 2008, Association of insurance with cancer care utilization and outcomes, CA Cancer J Clin, 58, 9, 10.3322/CA.2007.0011

Parikh-Patel, 2017, Disparities in quality of cancer care: the role of health insurance and population demographics, Medicine (Baltimore), 96, e9125., 10.1097/MD.0000000000009125

Thun, Cancer Epidemiology and Prevention, 10.1093/oso/9780190238667.001.0001

Benedict, 2018, Fertility information needs and concerns post-treatment contribute to lowered quality of life among young adult female cancer survivors, Support Care Cancer, 26, 2209, 10.1007/s00520-017-4006-z

Shay, 2017, Survivorship care planning and unmet information and service needs among adolescent and young adult cancer survivors, J Adolesc Young Adult Oncol, 6, 327, 10.1089/jayao.2016.0053

Thông tin
Thông tin xuất bản

Journal of the National Cancer Institute

Tập 111 Số 12

1279-1297

Thông tin tác giả